Oncology Account Manager, South West jobs in United States
cer-icon
Apply on Employer Site
company-logo

Verastem Oncology · 1 day ago

Oncology Account Manager, South West

Verastem Oncology is advancing innovation for patients with cancers driven by RAS/MAPK pathway mutations. The Oncology Account Manager will be responsible for launching Avutometinib and Defactinib, building customer relationships, and driving sales performance in the South West territory.

BiopharmaBiotechnologyPharmaceutical
check
Growth Opportunities

Responsibilities

Mastery of product clinical knowledge, and ability to articulate the value proposition of Avutometinib and Defactinib to customers
Demonstrate the ability to meet business objectives compliantly
Mastery of clinical and marketplace knowledge related to oncology
Develop and maintain a thorough understanding of assigned accounts and key customers and their perception of Avutometinib and Defactinib
Utilize approved resources to educate stakeholders in target accounts on the product benefits, safety and side effect management
Collaborate with stakeholders to provide account support in all facets of the patient journey
Demonstrate ability to understand complex account interdependencies to execute on both short and long-term account plans in conjunction with a wide array of stakeholders
Develop exceptionally well-designed business plans that align with brand strategic imperatives and allocate promotional resources efficiently and compliantly to lead to strong business results
Demonstrates a mastery of knowledge and analysis of business, products, technical issues, and the changing market landscape
Influence beyond their specific geography or product area by demonstrating advanced ability to ask strategic, insightful questions to obtain information on customer needs from all stakeholders in oncology accounts
Actively participate in all products, skills, and corporate training to improve personal and team skills
Be patient-focused with the ability to build and foster strong positive relationships with healthcare professionals and key opinion leaders
Exhibit strong collaboration and teamwork skills with internal and external stakeholders
Compliantly pull-through demand generation efforts with prescribers
Ability to identify and analyze trends in a complex buying environment. This includes the multiple channels of drug distribution, Oncology GPO’s, wholesalers and specialty pharmacies
Provide staff support as appropriate at exhibit booths and displays
Adheres to company and compliance guidelines, policies and procedures

Qualification

Oncology experiencePharmaceutical sales experienceBusiness acumenGYN/Oncology experienceOral drug experienceCross-functional collaborationCustomer relationship buildingCommunication skillsSelf-motivatedTeamwork skills

Required

Minimum of a BA/BS degree required
Minimum 10 years' relevant experience in pharmaceutical, biotech, or medical sales required
Minimum of 5 years Oncology and/or Rare Disease experience required
Ability to travel as required, which includes overnight and/or weekend travel; 50% overnight travel
Excellent written and oral communication skills
Strong cross-functional collaboration skills
Ability to comply with any customer credentialing and safety requirements (e.g., up-to-date vaccinations, trainings)
Passionate and self-motivated individual
Valid driver's license and clean driving record

Preferred

GYN/Oncology experience preferred
Oral drug experience preferred
Knowledge of geography and customer base preferred
Experience in launching new products and/or indications
Geographical account experience and strong relationships
Oral drug experience
Oncology experience in the gyn onc or ovarian space

Benefits

Annual bonus
Equity compensation
Competitive benefits package

Company

Verastem Oncology

twittertwittertwitter
company-logo
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Funding

Current Stage
Public Company
Total Funding
$626.6M
Key Investors
RTW InvestmentsOberland CapitalBiotechnology Value Fund
2025-11-14Post Ipo Equity· $90M
2025-04-25Post Ipo Equity· $75M
2025-01-13Post Ipo Equity· $7.5M

Leadership Team

leader-logo
Dan Paterson
President and CEO
linkedin
leader-logo
Dan Calkins
Chief Financial Officer
linkedin
Company data provided by crunchbase